Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Part of paid clinical trials in Hot Springs, Arkansas.
- Sponsor
- AbbVie
- Study ID
- NCT03339128
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Irritable Bowel Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Eluxadoline — DRUGOral tablets
- Placebo — DRUGOral tablets
Study Details
The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the safety and tolerability of eluxadoline in pediatric participants with IBS-D. Enrollment of 12-17 years old age group is closed, enrollment of the 6-11 years old age group will continue.
Key Dates
- Start date
- Nov 15, 2017
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 95 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Eluxadoline 25mgEluxadoline 25mg, oral administration, twice daily
- Experimental: Eluxadoline 50mgEluxadoline 50mg, oral administration, twice daily
- Experimental: Eluxadoline 100mgEluxadoline 100mg, oral administration, twice daily
- Experimental: PlaceboDose-matched placebo, oral administration, twice daily
Primary Outcome Measure
Change from baseline in stool consistency averaged over the 4-week Treatment Period [ Time Frame: Baseline (2 Weeks prior to randomization) to Week 4 ]
Central Contacts
- ABBVIE CALL CENTER844-663-3742
Locations (26)
Find similar trials in Hot Springs, AR
By research site
Related Studies
- Mucosal and Microbiota Changes During Acute CampylobacteriosisRecruiting · Mayo Clinic · Rochester, Minnesota
- A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)PHASE3 · Enrolling By Invitation · AbbVie · Corona, California
- Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel SyndromeRecruiting · The Cooper Health System · Camden, New Jersey
- Fecal Microbiota Transplantation for IBSPHASE2 · Recruiting · Madhusudan (Madhu) Grover, MBBS · Rochester, Minnesota